Hofseth BioCare ASA Celebrates Major Achievements in 2024
The Board of Directors of Hofseth BioCare ASA (Oslo: HBC) has made significant strides by approving the 2024 financial statements. Today, Hofseth BioCare released both the Annual Report and the Sustainability Report, showcasing their dedication to transparency and corporate responsibility.
Annual and Sustainability Reports Released
The newly published reports are essential resources for stakeholders and reflect Hofseth BioCare’s commitment to sustainable practices in the health sector. These documents provide insights into the company’s performance and initiatives aimed at maintaining ecological balance while enhancing consumer health.
Commitment to Consumer Health
Hofseth BioCare focuses on transforming side streams from the salmon industry into beneficial health products. Their flagship offerings include ProGo®, a blend of bioactive peptides and collagen, which supports iron metabolism and boosts energy levels. OmeGo®, a whole salmon oil, is recognized for its immune-boosting properties and has been shown to aid in recovery from illnesses and improve respiratory health. CalGo® is another innovative product that promotes bone and joint health, contributing to active lifestyles and successful aging.
Innovative Scientific Research and Patents
Hofseth BioCare prides itself on placing scientific research at the forefront of their product development. Their commitment has led to important partnerships with academic institutions, ensuring that their product offerings are backed by substantial evidence of health benefits.
Future Research Directions
The company's research has also led to valuable discoveries that resulted in several patents, focusing on unique health applications. Their biotech branch, HBC Immunology, is paving the way for innovative therapies, including treatments for prostate and ovarian cancer, along with non-steroidal therapies for asthma. Such advancements reflect Hofseth BioCare’s vision to address pressing health challenges through innovation.
Continuous Progress and Future Outlook
As Hofseth BioCare moves forward, the company is committed to enhancing its product portfolio while adhering to sustainability principles. By upcycling salmon by-products, they not only mitigate waste but also create nutritious solutions for consumers.
Engagement with the Community
Hofseth BioCare remains engaged with its consumers and stakeholders, facilitating open communication to garner feedback and foster community involvement. This commitment enhances not just the company’s practices but also builds a strong community of health-conscious individuals and organizations.
Conclusion
The release of the 2024 financial statements and accompanying reports marks a significant achievement for Hofseth BioCare ASA. By focusing on sustainability and harnessing innovation in health products, the company is poised to make an even greater impact in the health and wellness space going forward.
Frequently Asked Questions
What is Hofseth BioCare ASA?
Hofseth BioCare ASA is a Norwegian company that specializes in consumer and pet health products, emphasizing sustainability and the upcycling of salmon industry by-products.
What are the key products offered by Hofseth BioCare?
The company’s key products include ProGo®, OmeGo®, and CalGo®, all designed to promote various health benefits such as improved metabolism and joint health.
How does Hofseth BioCare ensure sustainability?
Hofseth BioCare focuses on utilizing resources from the salmon industry that would typically be considered waste, turning them into valuable health-enhancing ingredients.
What innovations has Hofseth BioCare introduced recently?
The company has introduced several research-backed products and has established a biotech branch to explore therapeutic applications in areas such as cancer treatment.
How can I contact Hofseth BioCare for more information?
You can reach out to Jon Olav Ødegård, CEO at Hofseth BioCare ASA, at +47 93632966 or via email at joo@hofsethbiocare.no for further inquiries.
